Artificial intelligence (AI) is playing an increasingly significant role in the healthcare sector, with Google DeepMind and CMR Surgical making noteworthy advancements. As per Statista, the market size of AI in healthcare is projected to grow from $20.65 billion in 2023 to a staggering $187.95 billion by 2030. These remarkable figures indicate that the AI healthcare sector is poised for rapid growth.
In a groundbreaking development, researchers at Google DeepMind have created an AI prediction model called AlphaMissense. This model aims to study the potential harmful effects of mutations in human genes. Missense mutations are DNA changes that result in different amino acids being encoded in the resulting protein. These mutations can alter the function of the protein, leading to various health issues. Conducting human experiments to study missense mutations can be expensive and time-consuming. However, the AlphaMissense tool allows researchers to predict the results for thousands of proteins simultaneously, enabling them to prioritize resources and accelerate more complex studies. While the predictions are not intended for clinical diagnosis, they can significantly increase the diagnosis rate of rare diseases. This development showcases the immense potential of AI in revolutionizing the healthcare sector.
Meanwhile, CMR Surgical, a UK-based robotic surgery company, has experienced a significant boost in funding. The company raised a remarkable $165 million from its existing investors, including SoftBank and Tencent. These funds will be utilized for product improvements and market penetration. CMR Surgical’s Versius system is responsible for conducting robotic surgeries for over 130 procedures. Robotic surgery is highly advantageous as it reduces patients’ pain and recovery time. Despite its benefits, robotic surgery currently accounts for only 3-4% of overall operations. However, CMR Surgical believes that this sector holds immense opportunities, especially as patients increasingly demand less invasive procedures.
The interest displayed by global tech giants like Google and Meta in AI healthcare further highlights the enormous potential of this technology. Using AI in the medical and healthcare sectors can aid in diagnosing rare diseases more efficiently and reducing the pain experienced during surgical procedures. With such promising prospects, it is no wonder that investors are making substantial investments in this sector.
In conclusion, AI is set to have a transformative impact on the future of healthcare. The recent developments by Google DeepMind and CMR Surgical illustrate the potential of AI to revolutionize the sector. The projected market growth of AI in healthcare from $20.65 billion in 2023 to $187.95 billion by 2030 further reinforces the notion that the AI healthcare sector is on the cusp of rapid expansion. With AI’s ability to diagnose rare diseases and enhance surgical procedures, it is clear that the healthcare sector will witness remarkable advancements driven by the power of artificial intelligence.
References:
– Statista: https://www.statista.com/
– Financial Times: https://www.ft.com/
– National Human Genome Research Institute: https://www.genome.gov/
